Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | MMP8 | P22894 | 1/20 | 0.49 |
| ▸ | F2 | P00734 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | F10 | P00742 | 1/20 | 0.45 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL295741 | 1.00 | ALDH1A1 (0.53) | ALDH1A1TSHRLMNAKDM4EMMP8 | |
| SCHEMBL10391474 | 1.00 | ALDH1A1 (0.53) | ALDH1A1TSHRLMNAKDM4EMMP8 | |
| SCHEMBL6544635 | 0.87 | ALDH1A1 (0.48) | ALDH1A1TSHRLMNAKDM4EMMP8 | |
| SCHEMBL7178642 | 0.85 | ALDH1A1 (0.55) | ALDH1A1TSHRLMNAMMP8F2 | |
| SCHEMBL4497421 | 0.84 | KMT2A (0.49) | ALDH1A1TSHRLMNAKDM4EKMT2A | |
| SCHEMBL4497426 | 0.84 | KMT2A (0.49) | ALDH1A1TSHRLMNAKDM4EKMT2A | |
| SCHEMBL232194 | 0.84 | F2 (0.59) | ALDH1A1TSHRMMP8F2MEN1 | |
| SCHEMBL27461469 | 0.83 | SMN1; SMN2 (0.58) | ALDH1A1TSHRLMNAMEN1KMT2A | |
| SCHEMBL5929625 | 0.83 | NAMPT (0.42) | ALDH1A1TSHRLMNAKDM4EKMT2A | |
| SCHEMBL6505602 | 0.83 | ALDH1A1 (0.49) | ALDH1A1TSHRLMNAKDM4EMMP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118513079-A | Polymer-coated mesoporous silica supported ruthenium catalyst and preparation method and application thereof | 浙江工业大学 | 2024-08-20 | — | — | CN | disclosed |
| WO-2022235866-A1 | COVALENT RAS INHIBITORS AND USES THEREOF | Revolution Medicines, Inc. (US) | 2022-11-10 | — | — | WO | disclosed |
| US-10668090-B2 | Liver specific delivery-based antiviral prodrug nucleoside cyclophosphate compound and uses thereof | ZHEJIANG PALO ALTO PHARMACEUTICALS, INC (CN) | 2020-06-02 | — | — | US | disclosed |
| US-20190125771-A1 | LIVER SPECIFIC DELIVERY-BASED ANTIVIRAL PRODRUG NUCLEOSIDE CYCLOPHOSPHATE COMPOUND AND USES THEREOF | ZHEJIANG PALO ALTO PHARMACEUTICALS,INC (CN) | 2019-05-02 | — | — | US | disclosed |
| EP-3476854-A1 | LIVER DELIVERY-BASED ANTIVIRAL PRECURSOR DRUG NUCLEOSIDE CYCLOPHOSPHATE COMPOUND AND USE THEREOF | Zhejiang Paloalto Pharmaceutical Technology Co Ltd (CN) | 2019-05-01 | — | — | EP | disclosed |
| CN-106366980-A | Corrosion-resistant anaerobic adhesive | 无锡万能胶粘剂有限公司 | 2017-02-01 | — | — | CN | disclosed |
| CN-102796068-A | Method for synthetizing (R)-(plus)-pinocembrin and (S)-(minus)-pinocembrin | INST MATERIA MEDICA CAMS | 2012-11-28 | — | — | CN | disclosed |
| CN-101230319-B | Saccharomyces cerevisiae CGMCC No.2266 and its application in preparation of (S)-(-)- beta-hydroxyphenyl propionic acid ethyl | UNIV ZHEJIANG TECHNOLOGY | 2010-06-02 | — | — | CN | disclosed |
| CN-101230319-A | Saccharomyces cerevisiae CGMCC No.2266 and its application in preparation of (S)-(-)- beta-hydroxyphenyl propionic acid ethyl | UNIV ZHEJIANG TECHNOLOGY (CN) | 2008-07-30 | — | — | CN | disclosed |
| CN-1768046-A | Amine-substituted diphenyldiphosphines and its application in asymmetric synthetic metal complex | SOLVIAS AG (CH) | 2006-05-03 | — | — | CN | disclosed |
| EP-0941231-B1 | Heteroarylic-arylic diphosphines as chiral ligands | CHEMI SPA (IT) | 2003-05-02 | — | — | EP | disclosed |
| US-6153758-A | Heteroarylic-arylic diphosphines as chiral ligands | CHEMI S.P.A. (IT) | 2000-11-28 | — | — | US | disclosed |
| EP-0941231-A1 | HETEROARYLIC-ARYLIC DIPHOSPHINES AS CHIRAL LIGANDS | CHEMI S.p.A. (IT) | 1999-09-15 | — | — | EP | disclosed |
| WO-1998022484-A1 | HETEROARYLIC-ARYLIC DIPHOSPHINES AS CHIRAL LIGANDS | CHEMI S.P.A. (IT) | 1998-05-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190125771-A1 | LIVER SPECIFIC DELIVERY-BASED ANTIVIRAL PRODRUG NUCLEOSIDE CYCLOPHOSPHATE COMPOUND AND USES THEREOF | SLC10A1, NPC1, NPC1L1 | ALDH1A1 2965/4885TSHR 4759/4885LMNA 2438/4885 |
| US-10668090-B2 | Liver specific delivery-based antiviral prodrug nucleoside cyclophosphate compound and uses thereof | SLC10A1, NPC1, NPC1L1 | ALDH1A1 2965/4885TSHR 4759/4885LMNA 2438/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.